Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic complication of controlled ovarian hyperstimulation (COH). Its pathogenesis is not clarified yet. In the recent years a number of studies focused on the vascular endothelial growth factor (VEGF) and antihtrombin III (AT III) indicators. VEGF is homodimeric, heparin-binding glycoprotein, stimulating vascular permeability. Antithrombin III is protease inhibitor of activated clotting factors. This study aimed at examining the VEGF-A165 and AT III indicators with two OHSS patients. Two methods were used for the determination of the indicators of VEGF-A165 and AT III: ELISA for VEGF and chromogenic assay for ATT III. Kits of R/D Systems and American Diagnostica Inc. were used to estimate VEGF and AT III indicators in serum and plasma. There were higher indicators of VEGF-A165 (180pg/ml) and reduction of AT III indicators (48%) in the patient with a severe form of OHSS than in the control group while these indicators were normal in the patient with a moderate form of OHSS. Our results confirmed some published data concerning the importance of VEGF and AT III in the genesis of OHSS. This study should include a larger group of patients in order tofollow-up statistically and authentically the variations of the indicators of both factors and their importance for OHSS.
Ковачев, E., И. Козовски, В. Маркова, С. Чернева, и др. Някои аспекта на ОХСС.- В: IV. Национален конгрес по стерилитет, контрацепция и хормонозаместителна терапия. Боровец, 2003 г.- Репрод. здраве, 2003, № 2.
Ковачев, E., И. Козовски, В. Маркова, С. Чернева, и др. Диагноза, клинична картина и проследяване на жени с ОХСС след ИВФ-ЕТ.- В: Юбилейна научна конференция. Стара Загора, 2002 г.
Козовски, И., В. Маркова, М. Андонов. ОХСС при бременност след ИВФ-ЕТ.- В: Национална акушерска конференция. Китен, 1997 г.
Козовски, И., В. Маркова, П. Шопова. ОХСС не е усложнение само на методите за асистирана репродукция,- В: VII. Национален конгрес по акушерство и гинекология. Варна, 1998 г.
Geva, E., J. В. Jaffe. Role of VEGF in ovarian physiology and pathology.- Fertil. Steril., 74, 2000, No 3, 429-438.
Neulen, J., D. Wenzel, C. Hornig, E. Wunsch, et al. Poor responder - high responder: the importanse of soluble VEGF-receptor 1 in ovarian stimulation protocols.- Hum. Reprod., 16, 2001, p. 84.
Levin, E. R., G. F.Rosen , D. Cassidenti , B.Yee, et al. Role of VEGF in ovarian hyperstimulation syndrome.- J. Clin. Invest., 102, 1998, 1978-1985.
Lee, A., L. Christenson, L. Stouffer , A. Burry, et al. VEGF levels in serum and follicular fluid of patients undergoing in vitro fertilization.- Fertil. Steril., 68, 1997, 305-311.
Ryo, E., D. Hagino, N. Yano, M. Sento, et al . A case of ovarian hyperstimulation syndrome in which antithrombin III deficiency occurred because of its loss into ascites.- Fertil. Steril., 71, 1999, 5.
Kligman, I., N. Noyes , C. A. Benadiva, Z. Rosenwaks, et al. Massive deep vein thrombosis in a patient with antithrombin III deficiency undergoing ovarian stimulation for in vitro fertilization.- Fertil. Steril., 63, 1995, 673-676.
Email this article (Login required) 
